• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

d-Propoxyphene kinetics after single oral and intravenous doses in man.

作者信息

Gram L F, Schou J, Way W L, Heltberg J, Bodin N O

出版信息

Clin Pharmacol Ther. 1979 Oct;26(4):473-82. doi: 10.1002/cpt1979264473.

DOI:10.1002/cpt1979264473
PMID:487695
Abstract

d-Propoxyphene kinetics was studied in 8 healthy male subjects after single oral doses of d-propoxyphene at 65, 130, and 190 mg and after slow intravenous infusion of 65 mg. Total urinary excretion (7 days) indicated complete oral absorption but systemic availability was reduced corresponding to fist-pass elimination of 30% to 70%. There was linearity between oral dose and the corresponding area under the plasma concentration/time curve of d-propoxyphene and the metabolite norpropoxyphene. The kinetic measurements showed 2- to 3-fold interindividual variations: oral clearance, 1.3 to 3.6 1/min; systemic clearance, 0.6 to 1.2 1/min; apparent volume of distribution, 700 to 1,800 1; d-propoxyphene half-life (t1/2), 8 to 24 hr; and norpropoxyphene t1/2, 18 to 29 hr. There were pronounced intraindividual dose-dependent variations in oral clearance in some subjects. The intravenous concentration curves indicated a 3-compartment distribution model.

摘要

相似文献

1
d-Propoxyphene kinetics after single oral and intravenous doses in man.
Clin Pharmacol Ther. 1979 Oct;26(4):473-82. doi: 10.1002/cpt1979264473.
2
D-propoxyphene and norpropoxyphene kinetics after the oral administration of D-propoxyphene: a new approach to liver function?
J Hepatol. 1994 Sep;21(3):283-91. doi: 10.1016/s0168-8278(05)80303-4.
3
Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient.
Clin Pharmacol Ther. 1980 May;27(5):665-70. doi: 10.1038/clpt.1980.94.
4
The effect of ethanol intake on propoxyphene absorption and biotransformation in dogs.乙醇摄入对犬体内丙氧芬吸收及生物转化的影响。
Alcohol Clin Exp Res. 1986 Aug;10(4):393-6. doi: 10.1111/j.1530-0277.1986.tb05111.x.
5
Propoxyphene and norpropoxyphene plasma concentrations after oral propoxyphene in cirrhotic patients with and without surgically constructed portacaval shunt.
Clin Pharmacol Ther. 1980 Sep;28(3):417-24. doi: 10.1038/clpt.1980.182.
6
Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene.
Clin Pharmacol Ther. 1982 Feb;31(2):157-67. doi: 10.1038/clpt.1982.25.
7
Dextropropoxyphene kinetics after single and repeated oral doses in man.右丙氧芬在人体单次及多次口服给药后的动力学
Eur J Clin Pharmacol. 1985;29(1):79-84. doi: 10.1007/BF00547373.
8
Determination of propoxyphene and norpropoxyphene by chemical ionization mass fragmentography.
Clin Pharmacol Ther. 1975 Jan;17(1):15-20. doi: 10.1002/cpt197517115.
9
Influence of first-pass effect on the systemic availability of propoxyphene.
J Clin Pharmacol New Drugs. 1972 Nov-Dec;12(11):449-52. doi: 10.1002/j.1552-4604.1972.tb00245.x.
10
Effect of hemodialysis on propoxyphene and norpropoxyphene concentrations in blood of anephric patients.
Clin Pharmacol Ther. 1980 Apr;27(4):508-14. doi: 10.1038/clpt.1980.71.

引用本文的文献

1
[Sustained-release dextropropoxyphene.].[缓释右丙氧芬。]
Schmerz. 1991 Dec;5(4):233-42. doi: 10.1007/BF02527803.
2
Pharmacokinetics of opioids in liver disease.阿片类药物在肝脏疾病中的药代动力学。
Clin Pharmacokinet. 1999 Jul;37(1):17-40. doi: 10.2165/00003088-199937010-00002.
3
Pharmacokinetics of opioids in renal dysfunction.肾功能不全患者中阿片类药物的药代动力学。
Clin Pharmacokinet. 1996 Dec;31(6):410-22. doi: 10.2165/00003088-199631060-00002.
4
Individual variation in first-pass metabolism.首过代谢的个体差异。
Clin Pharmacokinet. 1993 Oct;25(4):300-28. doi: 10.2165/00003088-199325040-00005.
5
Pharmacokinetics of drug overdose.药物过量的药代动力学。
Clin Pharmacokinet. 1981 May-Jun;6(3):161-92. doi: 10.2165/00003088-198106030-00001.
6
Drug metabolite concentration-time profiles: influence of route of drug administration.药物代谢物浓度-时间曲线:给药途径的影响
Br J Clin Pharmacol. 1984 Apr;17(4):385-94. doi: 10.1111/j.1365-2125.1984.tb02362.x.
7
D-propoxyphene kinetics in man: significance of a deep third compartment.D-丙氧芬在人体中的动力学:深部第三房室的意义。
Eur J Clin Pharmacol. 1984;26(6):749-52. doi: 10.1007/BF00541937.
8
First-pass elimination. Basic concepts and clinical consequences.首过消除。基本概念及临床后果。
Clin Pharmacokinet. 1984 Jan-Feb;9(1):1-25. doi: 10.2165/00003088-198409010-00001.
9
Dextropropoxyphene overdosage. Pharmacological considerations and clinical management.右丙氧芬过量。药理学考量与临床处理
Drugs. 1983 Jul;26(1):70-9. doi: 10.2165/00003495-198326010-00004.
10
Dextropropoxyphene kinetics after single and repeated oral doses in man.右丙氧芬在人体单次及多次口服给药后的动力学
Eur J Clin Pharmacol. 1985;29(1):79-84. doi: 10.1007/BF00547373.